TUESDAY, Jan. 12, 2021 -- Financial toxicity (FT) is associated
with worse quality of life (QOL) for breast cancer patients after mastectomy
or lumpectomy, according to a study published online Dec. 11 in the Journal
of the American College of Surgeons.
Christopher J. Coroneos, M.D., from McMaster University in
Hamilton, Ontario, Canada, and colleagues conducted a single-institution
cross-sectional survey of female breast cancer patients who underwent
lumpectomy or mastectomy between January 2018 and June 2019 to examine the
correlation between FT and QOL and patient satisfaction. The 11-item
Comprehensive Score for financial Toxicity (COST) instrument was used to
measure FT. Condition-specific and global QOL were assessed using the BREAST-Q
and 12-Item Short Form Health Survey (SF-12).
Data were included from 532 patients, with 64.3 percent
undergoing reconstruction. The researchers found that the mean COST score was
28.0, and median household income was $80,000 to $120,000 per year. A positive
relationship was seen for all outcomes after multivariable adjustment: Lower
COST (greater cost-associated distress) scores correlated with lower scores on
BREAST-Q and SF-12. The strongest correlation was seen for BREAST-Q
psychosocial well-being, with a 0.89 change per unit change in COST score.
"What clinicians have to do with these study results is to
consider the financial reserve patients have when discussing breast cancer
management," Coroneos said in a statement. "From a research
perspective, integrating the financial risk and patient reported outcomes can
inform decision-making models, and is especially important in vulnerable
populations."
Abstract/Full Text (subscription or
payment may be required)
https://www.drugs.com/news/financial-toxicity-linked-qol-after-breast-cancer-surgery-95153.html
No comments:
Post a Comment